article thumbnail

Leadership Matters

N2Growth Blog

Gordon Berridge: Our readers, with mining knowledge, will be will be familiar with the name Sam Walsh and Rio Tinto, but to provide a complete sketch of your background, would you please share a brief summary of your career history? Gordon Berridge: Would you please share what first attracted you to join Rio Tinto back in 1991?

Gordon 150
article thumbnail

Why We Need To Disseminate Innovation To Overcome The Productivity Paradox

The Horizons Tracker

It’s an argument that economists such as Robert Gordon believe carries little weight, and the problem is not so much that the various benefits provided by the technologies of the 4th industrial revolution cannot be captured, but that the technologies themselves are not utilized enough. in 2013, compared to 2.5%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reimagining Primary Care: When Small Is Beautiful

Harvard Business Review

Thanks to lower overhead, she is able to earn a full-time salary working part time. ”It’s actually very easy to run a solo ideal medical clinic in 2013,” she said. Dr. Gordon Moore of Rochester, New York traveled a parallel path. Follow the Leading Health Care Innovation insight center on Twitter @HBRhealth.

article thumbnail

We Need More Transparency on the Cost of Specialty Drugs

Harvard Business Review

Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary. In one analysis , Gordon D.

Cost 8
article thumbnail

We Need More Transparency on the Cost of Specialty Drugs

Harvard Business Review

Take Sovaldi, launched by Gilead Sciences in late 2013 as a treatment for hepatitis C virus (HCV) infection and recently superseded by Gilead’s newest drug, Harvoni. To illustrate the problem, let’s start with an example from October 2013, when Express Scripts decided to exclude 46 drugs from its formulary. In one analysis , Gordon D.

Cost 8
article thumbnail

From Zipcar to the Sharing Economy

Harvard Business Review

Avis has taken an interesting (and bold) step by acquiring Zipcar, absorbing an innovative but struggling competitor at what is likely to be seen as a bargain price while acquiring a small but desirable customer base and gaining a foothold in the rapidly growing world of collaborative consumption.

article thumbnail

Using Data to Increase Patient Engagement in Health Care

Harvard Business Review

As a result, we can rapidly innovate and improve our products. Inside the company, we sometimes refer to this initiative as “The Death of McKinsey,” an identifier not-so-loosely inspired by a blog post from Gordon Ritter and motivated further by a 2013 Clayton Christensen HBR article.